ATRI Appoints New Executive Leadership to Drive Trucking Research Initiatives
The American Transportation Research Institute names a new executive leader to oversee its non-profit research operations and advance industry-wide logistics initiatives.
Stocks: the latest market news with AI summary, sentiment and the assets affected, updated around the clock.
The American Transportation Research Institute names a new executive leader to oversee its non-profit research operations and advance industry-wide logistics initiatives.
Boxwood Partners leadership joins the International Franchise Association board, reinforcing the firm's commitment to the franchising sector and M&A advisory expertise.
Pet brand Joyride Dogs grows its US-sourced product line, focusing on simple, transparent ingredients for its expanding customer base of over one…
Accessory maker ROKFORM debuts a specialized rugged case for Apple's first foldable iPhone, highlighting enhanced magnetic connectivity and compatibility with its proprietary…
Gabriel Tavares nets $204,657 in back-to-back Sunday Banana wins on Americas Cardroom and advances in the $5 Million GTD NLH Venom PKO…
Vale Base Metals offloads the Thompson Mine Complex to Exiro Nickel in a $200 million transaction, while retaining a minority interest and…
Universal Music Entertainment has released the long-awaited self-titled album from Trailer Park Pam, a project originally recorded in 2001 and held back…
Rhodovi succeeds founder Marcia Nusgart as CEO of the Alliance of Wound Care Stakeholders, bringing deep expertise in reimbursement and payer relations…
Hitachi Energy announces a $479 million CAD investment in a new Ontario facility to establish Canada's first pressboard manufacturing line, significantly strengthening…
Cousins Maine Lobster brings its signature seafood offerings to five Texas cities, bridging the gap between the border and the Gulf Coast…
Cyrano Therapeutics earns a spot in the Top 5 Clinical Science track at the 72nd American Rhinologic Society meeting, underscoring the company's…
Actinium Pharmaceuticals shares gain momentum as new clinical data from EANM 2026 confirms ATNM-400's broad antitumor activity across diverse cancer models, including…